tirzepatide semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Tirzepatide Outperforms Semaglutide in Blood

Significant hypoglycemia risk mainly arises when semaglutide is combined with insulin or sulfonylureas, not typically as monotherapy

The most striking difference between the two classes of drugs relates to the amelioration on hospitalization for HF, as the benefit of SGLT-2 inhibitors surpass by threefold that obtained with GLP-1RA

Berberine as a Bioactive Alkaloid: Multi-Omics Perspectives on Its Role in Obesity Management

Week 17+: 2.4 mg subcutaneous once weekly (maintenance)

CWCK has received grants or research support from the Advanced Food Materials Network, Agriculture and Agri-Foods Canada (AAFC), Almond Board of California, Barilla, Canadian Institutes of Health Research (CIHR), Canola Council of Canada, International Nut and Dried Fruit Council, International Tree Nut Council Research and Education Foundation, Loblaw Brands Ltd, the Peanut Institute, Pulse Canada, and Unilever

In addition, we included reviews of the existing literature on this topic